SynapCell
PrivateLast Round
Grant
Jan 10, 2023
Total Funding Raised
$1.99M
Company Overview
SynapCell is a biotechnology company that operates as a preclinical contract research organization specializing in translational EEG to evaluate drug candidates for central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynapCell Comparables
Compare SynapCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| E-Phy-Science | 86% | |
| Neuroservices-Alliance | 86% | |
| PsychoGenics Inc. | 86% |
SynapCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 10, 2023 | ||||
| VC Round | Nov 5, 2010 | ||||
| Seed | Feb 1, 2009 |
Key People
Founding team and executive leadership
SynapCell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Grenoble Angels | Seed, VC Round |
| Kreaxi | Seed, VC Round |
| Bpifrance | Grant |
| Expansinvest | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
Monthly visitors grew 450% MoM, reaching 1.1K.
- Jan 10, 2023
$1.29M grant received from Bpifrance.
Recent news
Latest coverage and updates
- launchesSep 22, 2026
SynapCell will launch Cue-based AI-powered offering at Neuroscience 2026 on Nov 17th '26.
SynapCell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SynapCell's valuation, stock price, and market status.
Is SynapCell a public or private company?
SynapCell is a private company.
What is the current stock price of SynapCell?
SynapCell is a private company with no public stock price. No recent secondary market data is available.
How much is SynapCell worth (valuation)?
Valuation information for SynapCell is not publicly available.
Can I buy SynapCell stock?
SynapCell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SynapCell's last funding round?
SynapCell's most recent funding round was Grant on January 10, 2023.
Who are the main investors in SynapCell?
Key investors in SynapCell include Kreaxi.
Will SynapCell IPO soon?
No public IPO plans have been announced for SynapCell.
How can I track SynapCell secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SynapCell's secondary market activity and sign up for updates.